Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study (Q44303602)

1 December 2017

title

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study (English)

1 reference

Hormone Replacement Therapy

1 December 2017

0 references

1 reference

6

Duk L Na

1 reference

1 December 2017

Byung-Koo Yoon

1

1 reference

1 December 2017

Doh Kwan Kim

2

1 reference

1 December 2017

Yeonwook Kang

3

1 reference

1 December 2017

Jong-Won Kim

4

1 reference

1 December 2017

Myung-Hee Shin

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

published in

Fertility and Sterility

1 reference

1 December 2017

volume

79

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

274-280

1 reference

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

A new clinical scale for the staging of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Normative data on the Korean version of the Boston Naming Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Clinical research designs for emerging treatments for Alzheimer disease: moving beyond placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

High-dose estradiol improves cognition for women with AD: results of a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Motherhood improves learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Estrogenic effects on memory in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Menopausal progesterone replacement and sleep quality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Effect of Tacrine on Language, Praxis, and Noncognitive Behavioral Problems in Alzheimer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04666-6

10.1016/S0015-0282(02)04666-6

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference